31/03/2003
ReGen Therapeutics Plc (‘ReGen’ or ‘the Company’) announces that at the Extraordinary General Meeting of the Company held earlier today (the ‘EGM’), Shareholders passed all of the resolutions proposed including those relating to the capital reorganisation, as detailed in the circular sent to shareholders dated 7 March 2003 (the ‘Capital Reorganisation’).
It is anticipated that the Capital Reorganisation will take effect tomorrow, 1 April 2003, whereupon the new ordinary shares of 0.1p each arising on the Capital Reorganisation (the ‘New Ordinary Shares’) will be admitted to trading on the Alternative Investment Market of the London Stock Exchange plc (‘AIM’).
Replacement certificates will not be sent out in relation to the New Ordinary Shares as existing share certificates will remain valid in relation to the number of New Ordinary Shares that each shareholder is entitled to following the Capital Reorganisation. Certificates will not be issued for the deferred shares of 4.9p each arising on the Capital Reorganisation. Shareholders who currently hold their existing ordinary shares in ReGen in uncertificated form will have their CREST accounts credited with the New Ordinary Shares following their admission to AIM. The Deferred Shares will not be eligible for settlement through CREST.
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033